Fabrizio Montecucco researcher
Montecucco, Fabrizio
VIAF ID: 208144782967851167587 (Personal)
Permalink: http://viaf.org/viaf/208144782967851167587
Preferred Forms
- 100 0 _ ‡a Fabrizio Montecucco ‡c researcher
-
4xx's: Alternate Name Forms (2)
Works
Title | Sources |
---|---|
Effect of blockage of the endocannabinoid system by CB1 antagonism on cardiovascular risk | |
Insulin resistance: a proinflammatory state mediated by lipid-induced signaling dysfunction and involved in atherosclerotic plaque instability | |
Interleukin-1β Mediates Arterial Thrombus Formation via NET-Associated Tissue Factor | |
Intestinal radiation-induced stricture favours small bowel obstruction by phytobezoar: report of a case | |
Ischemic stroke across sexes: What is the status quo? | |
Left atrial thrombosis in an anticoagulated patient after bioprosthetic valve replacement: Report of a case | |
Leptin/adiponectin ratio predicts poststroke neurological outcome. | |
Levels of serum uric acid at admission for hypoglycaemia predict 1-year mortality. | |
Low serum C-reactive protein levels predict 90-day mortality in hypoglycaemic patients. | |
Macrophages in the pathophysiology of NAFLD: the role of sex differences | |
Mas receptor deficiency is associated with worsening of lipid profile and severe hepatic steatosis in ApoE-knockout mice. | |
Matrix metalloproteinase-9: a deleterious link between hepatic ischemia-reperfusion and colorectal cancer | |
MELAS Syndrome with Cardiac Involvement: A Multimodality Imaging Approach. | |
Methylene blue: potential use of an antique molecule in vasoplegic syndrome during cardiac surgery. | |
Monocyte count at onset predicts poststroke outcomes during a 90-day follow-up. | |
Morphology of atherosclerotic coronary arteries | |
Mutation Analysis of PRKAR1A Gene in a Patient with Atrial Myxoma | |
Myostatin mediates abdominal aortic atherosclerosis progression by inducing vascular smooth muscle cell dysfunction and monocyte recruitment. | |
Nephrotic syndrome in a patient with IgM myeloma with associated neutrophilia | |
Neutrophil migration towards C5a and CXCL8 is prevented by non-steroidal anti-inflammatory drugs via inhibition of different pathways | |
New allies against old foe: Transcriptomic in idiopathic pulmonary fibrosis | |
New evidence for nicotinic acid treatment to reduce atherosclerosis | |
New evidences for C-reactive protein (CRP) deposits in the arterial intima as a cardiovascular risk factor | |
New Hybrid Pyrazole and Imidazopyrazole Antinflammatory Agents Able to Reduce ROS Production in Different Biological Targets | |
New insights into the role of DNA methylation in cardiovascular disease | |
Nicotinamide phosphoribosyltransferase (NAMPT) inhibitors as therapeutics: rationales, controversies, clinical experience. | |
Nonleukoreduced red blood cell transfusion induces a sustained inhibition of neutrophil chemotaxis by stimulating in vivo production of transforming growth factor-beta1 by neutrophils: role of the immunoglobulinlike transcript 1, sFasL, and sHLA-I. | |
Novel findings in neutrophil biology and their impact on cardiovascular disease | |
O043 Treatment with chemokine-binding protein Evasin-3 reduces atherosclerotic vulnerability for ischemic stroke in mice | |
Obesity phenotypes and their paradoxical association with cardiovascular diseases. | |
An oral formulation of angiotensin-(1-7) reverses corpus cavernosum damages induced by hypercholesterolemia. | |
Oxaprozin-induced apoptosis on CD40 ligand-treated human primary monocytes is associated with the modulation of defined intracellular pathways | |
Oxidative burden in familial hypercholesterolemia. | |
P660Molecular insight in apoM-S1P-induced cardioprotection against ischemia/reperfusion injury | |
Pathophysiological relevance of macrophage subsets in atherogenesis | |
Pathophysiological role of inflammatory molecules in paediatric ischaemic brain injury | |
Pathophysiology and Treatments of Oxidative Injury in Ischemic Stroke: Focus on the Phagocytic NADPH Oxidase 2 | |
Pathophysiology of ST-segment elevation myocardial infarction: novel mechanisms and treatments. | |
PCSK9 is a promising prognostic marker in patients with advanced NSCLC | |
PCSK9 is associated with mortality in patients with septic shock: data from the ALBIOS study | |
Pericardial adipose tissue and cardiovascular diseases: New insights from basic research | |
Pharmacologic strategies to reduce cardiovascular disease in type 2 diabetes mellitus: focus on SGLT-2 inhibitors and GLP-1 receptor agonists | |
Plaque vulnerability and adverse outcomes: the long road to effectively fight atherosclerosis | |
Plasma palmitoylethanolamide (PEA) as a potential biomarker for impaired coronary function. | |
Platelet-to-lymphocyte ratio at the time of carotid endarterectomy is associated with acute coronary syndrome occurrence | |
Post-ischaemic administration of the murine Canakinumab-surrogate antibody improves outcome in experimental stroke | |
Potential pathophysiological role for the vitamin D deficiency in essential hypertension. | |
Potential useful prognostic parameters after transcatheter aortic valve implantation: editorial | |
Pre-hospital alarm activation for STEMI patients undergoing primary percutaneous coronary intervention in the era of transradial procedures | |
Pre-surgery age-adjusted Charlson Comorbidity Index is associated with worse outcomes in acute cholecystitis | |
Predictors of cardiovascular outcome and re-hospitalization in elderly patients with heart failure | |
Protective role of necrostatin-1 in acute myocardial infarction. | |
Receptor activator of NF- κB ligand (RANKL) increases the release of neutrophil products associated with coronary vulnerability. | |
Receptor activator of nuclear factor kappa B ligand/osteoprotegerin pathway is a promising target to reduce atherosclerotic plaque calcification | |
Recombinant tissue plasminogen activator enhances microglial cell recruitment after stroke in mice | |
Recombinant Tissue Plasminogen Activator (r-tPA) Induces In-Vitro Human Neutrophil Migration via Low Density Lipoprotein Receptor-Related Protein 1 (LRP-1) | |
Reduction in TIMP-2 serum levels predicts remission of inflammatory bowel diseases | |
Regulation and Function of Extracellular Nicotinamide Phosphoribosyltransferase/Visfatin | |
Regulation and possible role of endocannabinoids and related mediators in hypercholesterolemic mice with atherosclerosis | |
Relationship between HDL Cholesterol Efflux Capacity, Calcium Coronary Artery Content, and Antibodies against ApolipoproteinA-1 in Obese and Healthy Subjects | |
Reply to "Management of left ventricular thrombosis in patients with apical aneurysm". | |
Reply to “Osteopontin inhibits macrophage cholesterol efflux via NF-κB/ABCA1 pathway” | |
Reply to “PCSK9: Entering a new era of cardiovascular risk prediction” | |
Reply to “Precipitants of heart failure must be fully considered when predicting readmission” | |
Research update for articles published in EJCI in 2014 | |
Resistin exerts a beneficial role in atherosclerotic plaque inflammation by inhibiting neutrophil migration | |
Resistin is associated with overall survival in non-small cell lung cancer patients during nivolumab treatment | |
Retinal pigment epithelial cells express a functional receptor for glucagon-like peptide-1 (GLP-1). | |
Role of CCL-2, CCR-2 and CCR-4 in cerulein-induced acute pancreatitis and pancreatitis-associated lung injury | |
Role of cytokines and chemokines in non-alcoholic fatty liver disease | |
Role of matrix metalloproteinases in animal models of ischemic stroke. | |
Role of mitogen-activated protein kinase pathways in multifactorial adverse cardiac remodeling associated with metabolic syndrome | |
Role of NADPH oxidase isoforms NOX1, NOX2 and NOX4 in myocardial ischemia/reperfusion injury | |
Role of neutrophils in atherogenesis: an update | |
Role of renin-angiotensin system in inflammation, immunity and aging. | |
Role of the renin-angiotensin system on abdominal aortic aneurysms. | |
Sepsis by Pasteurella multocida in an Elderly Immunocompetent Patient after a Cat Bite. | |
Serum cardiovascular risk biomarkers in pre-pubertal obese children | |
Serum levels of anti-apolipoprotein A-1 auto-antibodies and myeloperoxidase as predictors of major adverse cardiovascular events after carotid endarterectomy | |
Serum lipoprotein (a) predicts acute coronary syndromes in patients with severe carotid stenosis. | |
Serum osteopontin levels are upregulated and predict disability after an ischaemic stroke | |
Serum osteopontin negatively impacts on intima-media thickness in patients with systemic lupus erythematosus | |
Statins and the COVID-19 main protease : in silico evidence on direct interaction |